Controlling Use of Antimicrobial Agents

Infection Control and Hospital Epidemiology

Volumn 18, Issue 4, 1997, Pages 260-266

  Duncan, Robert A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CASE MANAGEMENT; CROSS INFECTION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOSPITAL INFORMATION SYSTEM; HUMAN; INFECTION CONTROL; INFORMATION PROCESSING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROFESSIONAL PRACTICE; PROGRAM DEVELOPMENT;

ANTI-INFECTIVE AGENTS; CASE MANAGEMENT; CROSS INFECTION; DATA COLLECTION; DRUG RESISTANCE, MICROBIAL; HOSPITAL INFORMATION SYSTEMS; HUMANS; INFECTION CONTROL; INFECTION CONTROL PRACTITIONERS; PATIENT CARE TEAM; PROFESSIONAL AUTONOMY; PROGRAM DEVELOPMENT; PROGRAM EVALUATION;

EID: 0031113157     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141213     Document Type: Article

References (19)

1. Kunin CM. Problems in antibiotic usage. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990:427-434.
2. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-1048.
3. Tomasz A. Multiple-antibiotic agent-resistant pathogenic bacteria: a report on the Rockefeller University Workshop. N Engl J Med 1994;330:1247-1251.
4. Neu HC. The crisis in antibiotic resistance. Science 1992; 257:1064-1073.
5. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Guidelines for the prevention of antimicrobial resistance in hospitals: a report from the Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Infect Control Hosp Epidemiol 1997;18:275-291.
6. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234-240.
7. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988; 157:869-876.
8. McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-483.
9. Bryan CS. Strategies to improve antibiotic use. Infect Dis Clin North Am 1989;3:723-734.
10. Kunin CM. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis 1985;3:388-398.
11. Blaser J, Koenig C. Once-daily dosing of aminoglycosides. European Journal of Microbiology and Infectious Disease 1995;14:1029-1038.
12. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
13. Nightingale CH, Quintiliani R, Nicolau DP. Intelligent dosing of antimicrobials. Current Clin Top Infect Dis 1994;14:252-265.
14. Duncan RA, Segarra M, Anderson ER, Chow LS, Needham C, Jacoby GA. A comprehensive approach to reforming therapeutic antibiotic (ABx) use. Infect Control Hosp Epidemiol 1995;16(suppl):37. Abstract M7.
15. Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 1994;154:878-884.
16. Pestotnik SL, Evans RS, Burke JP, et al. Therapeutic antibiotic monitoring: surveillance using a computerized expert system. Am J Med 1990;88:43-48.
17. Pestotnik SL, Classen DC, Evans RS, Burke JR Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-890.
18. Monnet D. Relationship between antibiotic resistance and antibiotic use. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, CA; September 17-20, 1995. Abstract S21.
19. Monnet D, Gaynes R, Tenover F, McGowan J, ICARE pilot hospitals. Ceftazidime-resistant Pseudomonas aeruginosa (PA) and ceftazidime (CFZ) usage in NNIS hospitals: preliminary results of project ICARE phase one. Infect Control Hosp Epidemiol 1995;16;4(suppl):19. Abstract 22.